Related references
Note: Only part of the references are listed.Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension
Riitta Sallinen et al.
ANNALS OF MEDICINE (2010)
Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy
Eliecer Coto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium
Linda E. Kelemen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
B. Tomlinson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort
Daniel F. Carr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans
Michael Man et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements
Kendra A. Ross et al.
JOURNAL OF HUMAN GENETICS (2010)
Integrating common and rare genetic variation in diverse human populations
David M. Altshuler et al.
NATURE (2010)
Target-enrichment strategies for next-generation sequencing
Lira Mamanova et al.
NATURE METHODS (2010)
APPLICATIONS OF NEXT-GENERATION SEQUENCING Sequencing technologies - the next generation
Michael L. Metzker
NATURE REVIEWS GENETICS (2010)
Allele-Specific Down-Regulation of RPTOR Expression Induced by Retinoids Contributes to Climate Adaptations
Chang Sun et al.
PLOS GENETICS (2010)
Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2
Joshua A. Szental et al.
INTERNATIONAL OPHTHALMOLOGY (2010)
CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients
Awewura Kwara et al.
AIDS (2009)
Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma
Hee Nam Kim et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
The Global Pattern of Gene Identity Variation Reveals a History of Long-Range Migrations, Bottlenecks, and Local Mate Exchange: Implications for Biological Race
Keith L. Hunley et al.
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY (2009)
Genome wide signatures of positive selection: The comparison of independent samples and the identification of regions associated to traits
William Barendse et al.
BMC GENOMICS (2009)
Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort
Elise Jeannesson et al.
CLINICA CHIMICA ACTA (2009)
Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
Dong Hwan (Dennis) Kim et al.
CLINICAL CANCER RESEARCH (2009)
The Increasing Complexity of Mercaptopurine Pharmacogenomics
S. Marsh et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
In Vitro Glucuronidation of Fenofibric Acid by Human UDP-Glucuronosyltransferases and Liver Microsomes
Jelena Tojcic et al.
DRUG METABOLISM AND DISPOSITION (2009)
Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole
Su-Jun Lee et al.
DRUG METABOLISM AND DISPOSITION (2009)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Molecular Population Genetics of Human CYP3A Locus: Signatures of Positive Selection and Implications for Evolutionary Environmental Medicine
Xiaoping Chen et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Genetically based impairment in CYP2C8-and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
Jose A. G. Agundez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Signals of recent positive selection in a worldwide sample of human populations
Joseph K. Pickrell et al.
GENOME RESEARCH (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease
Silvia Sookoian et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
The Drug Transporter-Metabolism Alliance: Uncovering and Defining the Interplay
Leslie Z. Benet
MOLECULAR PHARMACEUTICS (2009)
SLCO1B1 Variants and Statin-Induced Myopathy
Georgirene D. Vladutiu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Variation in the Proximal Promoter of ABC and SLC Superfamilies: Liver and Kidney Specific Expression and Promoter Activity Predict Variation
Stephanie E. Hesselson et al.
PLOS ONE (2009)
Genetic Variation and Recent Positive Selection in Worldwide Human Populations: Evidence from Nearly 1 Million SNPs
David Lopez Herraez et al.
PLOS ONE (2009)
Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
Johanna Sistonen et al.
PHARMACOGENETICS AND GENOMICS (2009)
Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes
M. Karazniewicz-Lada et al.
XENOBIOTICA (2009)
Fine-Scale Variation and Genetic Determinants of Alternative Splicing across Individuals
Jasmin Coulombe-Huntington et al.
PLOS GENETICS (2009)
The Role of Geography in Human Adaptation
Graham Coop et al.
PLOS GENETICS (2009)
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
Kazuma Kiyotani et al.
CANCER SCIENCE (2008)
Unraveling ambiguous NAT2 genotyping data
Jose A. G. Agundez et al.
CLINICAL CHEMISTRY (2008)
Developmental changes in human liver CYP2D6 expression
Jeffrey C. Stevens et al.
DRUG METABOLISM AND DISPOSITION (2008)
Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations
Francesca Luca et al.
PLOS ONE (2008)
CYP3 phylogenornics: evidence for positive selection of CYP3A4 and CYP3A7
Huan Qiu et al.
PHARMACOGENETICS AND GENOMICS (2008)
Global analysis of genetic variation in SLCOIB1
Marja K. Pasanen et al.
PHARMACOGENOMICS (2008)
Worldwide human relationships inferred from genome-wide patterns of variation
Jun Z. Li et al.
SCIENCE (2008)
Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia
Helene Magalon et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Recent and ongoing selection in the human genome
Rasmus Nielsen et al.
NATURE REVIEWS GENETICS (2007)
Factors influencing warfarin dose requirements in African-Americans
Kathryn M. Momary et al.
PHARMACOGENOMICS (2007)
Routine pharmacogenetic testing in clinical practice: dream or reality?
Iris Grossman
PHARMACOGENOMICS (2007)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A new approach for using genome scans to detect recent positive selection in the human genome
Kun Tang et al.
PLOS BIOLOGY (2007)
Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport
Thomas M. Daly et al.
CLINICAL CHEMISTRY (2007)
ABCB1 genotype and PGP expression, function and therapeutic drug response:: a critical review and recommendations for future research
G. D. Leschziner et al.
PHARMACOGENOMICS JOURNAL (2007)
Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix® Targeted Genotyping System
Carmen Dumaual et al.
PHARMACOGENOMICS (2007)
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the cocktail approach
U. Fuhr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins
Kim D. Pruitt et al.
NUCLEIC ACIDS RESEARCH (2007)
Standardized subsets of the HGDP-CEPH human genome diversity cell line panel, accounting for atypical and duplicated samples and pairs of close relatives
Noah A. Rosenberg
ANNALS OF HUMAN GENETICS (2006)
Can we estimate the accuracy of ADME-Tox predictions?
Igor V. Tetko et al.
DRUG DISCOVERY TODAY (2006)
Sub-Saharan African Coding Sequence Variation and Haplotype Diversity at the NAT2 Gene
Etienne Patin et al.
HUMAN MUTATION (2006)
A map of recent positive selection in the human genome (vol 4, pg 154, 2006)
BF Voight et al.
PLOS BIOLOGY (2006)
A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase
P Scheet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
A map of recent positive selection in the human genome
BF Voight et al.
PLOS BIOLOGY (2006)
TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits
BM Hemminger et al.
BIOINFORMATICS (2006)
Pharmacogenetics, drug-metabolizing enzymes, and clinical practice
Sharon J. Gardiner et al.
PHARMACOLOGICAL REVIEWS (2006)
Genomic scans for selective sweeps using SNP data
R Nielsen et al.
GENOME RESEARCH (2005)
Molecular signatures of natural selection
R Nielsen
ANNUAL REVIEW OF GENETICS (2005)
Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection
SK Balani et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Genomic evidence for recent positive selection at the human MDR1 gene locus
K Tang et al.
HUMAN MOLECULAR GENETICS (2004)
CYP3A variation and the evolution of salt-sensitivity variants
EE Thompson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Genetic variants of the human H+/dpeptide transporter PEPT2:: Analysis of haplotype functions
J Pinsonneault et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population
AO Ada et al.
TOXICOLOGY LETTERS (2004)
Markers of genetic susceptibility in human environmental hygiene and toxicology:: The role of selected CYP, NAT and GST genes
R Thier et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2003)
Polymorphism of cytochrome P450 and xenobiotic toxicity
M Ingelman-Sundberg
TOXICOLOGY (2002)
Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations
K Tang et al.
PHARMACOGENETICS (2002)
CYP gene polymorphisms and early menarche
J Lai et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Population genetic structure of variable drug response
JF Wilson et al.
NATURE GENETICS (2001)
Share Paper
